Stock Information
  Corporate Presentation
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request







(NASDAQ DRRX) 2.74   --0.03

  Stock Information
  Corporate Presentation
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request


The Company currently has several late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.



Webcast ImageWebcast
DURECT Corporation at Cowen and Company Healthcare Conference (Replay)
03/08/10 at 3:15 p.m. ET

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.

... 
More >>
Featured Report
Download Documentation DURECT 2008 Annual Report
DRRX (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Price$2.74
Change (%) Stock is Down 0.03 (1.08%)
Volume191,107
Data as of 03/12/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
03/01/10DURECT to Present at the Cowen and Company Healthcare ConferencePrinter Friendly Version
02/24/10DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial ResultsPrinter Friendly Version
02/22/10DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand TerritoryPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever DURECT Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Transfer Agent
Computershare Trust Company N.A.
250 Royall Street, Mailstop 3B
Canton, MA 02021
Phone: 781- 575-3400

Accountants
Ernst & Young LLP
1001 Page Mill Road
Palo Alto, CA 94304
Phone: 650-496-1600
Fax: 650-496-1600

Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.




© 2000-2009 DURECT Corporation
Last updated: September 20, 2006
Search    Contact    Site Index    Legal Notice    Privacy Policy  


 
 © 2000-2010 DURECT Corporation
Last updated: March 11, 2010
Search     Contact     Site Index     Legal Notice     Privacy Policy